2022 annual financial data
Avalo Therapeutics 2022 Operating margin
Direct answer
Operating margin was -207.41%.
Operating income was -37,440,000 USD and net income was -41,658,000 USD.
Operating cash flow was -26,751,000 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,051,000 USD
- Operating income
- -37,440,000 USD
- Net income
- -41,658,000 USD
- Operating cash flow
- -26,751,000 USD